⌕ Zoom

Photo from the brand's official website

Vlado's Himalayan Organics

Apple Cider Vinegar 500mg

Name: Apple Cider Vinegar 500mg
Brand: Vlado's Himalayan Organics

Clean SafeShelf · review pending

NOVA 4vegetarian capsulesfssai registeredayurvedic blendno artificial coloursno added sugarlactose-freegluten-freediabetic-safenut-freepregnancy-safeenjoy in moderation

Serving

—

Pack

—

Ingredients

Barcode

8906113262361

Buy on Amazon

01 — Ingredient mix

What’s in the box, ranked from most concerning.

Each ingredient gets a tier from our researched dossier. The list sorts worst-first; the donut summarises the distribution. Tap any ingredient for its full dossier.

Cleared · 3 ingredients shown

Cleared3 of 3 ingredients

Apple Cider Vinegar 8%Cleared

Dibasic Calcium PhosphateE341(ii)Cleared

Triphala PowderCleared

02 — Claims audit

Every label claim, fact-checked.

We treat each claim as a question — does what’s inside back it up? Tap a claim for the reasoning.

1/8

claims fully supported

“Healthy Weight Management & Body Detoxification”unverified

Neither ACV at 500 mg nor Triphala has demonstrated clinically significant weight loss or detoxification outcomes in well-controlled human trials at this encapsulated dose; no study citation provided.

“Helps in Weight Loss”unverified

Human evidence for ACV's effect on weight loss is limited to small studies using liquid ACV (15–30 mL/day), far exceeding the 500 mg capsule equivalent here; Triphala has modest animal-model data only.

“Promotes Glowing Skin”unverified

No ingredient in this formulation has peer-reviewed evidence linking oral supplementation at these doses to measurable skin luminosity or appearance improvements.

“Helps in Energy Boost”unverified

No ingredient dossier or nutritional data supports an energy-boosting mechanism at this dose; acetate from ACV is a metabolic substrate but not an ergogenic at supplemental levels.

“Helps Maintain Blood-sugar”misleading

ACV has documented evidence for blunting postprandial glucose spikes and Triphala inhibits alpha-amylase/alpha-glucosidase, supporting a plausible mechanism — however, this also raises hypoglycaemia risk in diabetics on medication, so the claim is directionally supported but misleadingly framed as universally beneficial.

“Weight Management”unverified

See 'Helps in Weight Loss' above — evidence at this dose and delivery form is insufficient to support the claim.

“Healthy Cholesterol”unverified

No ingredient dossier entry, nutrition data, or cited study in the available information supports a cholesterol-modulating effect for this formulation.

“Vegetarian Capsules”true

Confirmed in EXTRA INFORMATION: capsuleType field explicitly states '90 Vegetarian Capsules'; vegetarianStatus is also recorded as 'veg'.

03 — The fuller picture

Read the whole thing if a one-line verdict isn’t enough.

What’s in favour, and what’s working against it

In favour

FSSAI licensed for both manufacturer and distributor
Vegetarian capsule format confirmed on label
No artificial colours, sweeteners, or preservatives
No added sugars or sodium-containing additives
Triphala is a well-documented Ayurvedic antioxidant blend
ACV may modestly support post-meal blood glucose response in healthy adults

Working against

Weight loss, skin, and energy claims unsubstantiated at 500 mg dose
Triphala inhibits CYP1A2, CYP3A4, CYP2C9, CYP2D6 — significant drug-interaction risk
Dibasic Calcium Phosphate may push phosphate intake above EFSA ADI for children and kidney patients
No nutrition panel data available; serving calorie and macro content unknown
No batch number or expiry date present in label data
Cholesterol and detoxification claims are unverified by any ingredient-level evidence

Who should approach with care

Pregnancy — Triphala's stimulant laxative properties and absence of controlled human pregnancy-safety data, combined with the risk from potentially unpasteurised ACV (Listeria, E. coli), warrant physician clearance before use.

Lactation — Triphala's bioactive polyphenols (gallic acid, ellagic acid) have no controlled data on transfer into breast milk, making this supplement unsuitable without medical guidance during lactation.

Infants — Triphala has no safety data or regulatory approval for infant use, and ACV's acidity poses a direct mucosal injury risk in this age group.

Children — ACV's acidity can damage dental enamel and oesophageal mucosa in children; Triphala lacks paediatric dosing data; and Dibasic Calcium Phosphate may push phosphate intake above EFSA's ADI for young populations.

Diabetes — Both ACV and Triphala independently lower blood glucose by distinct mechanisms; concurrent use with insulin or oral antidiabetic drugs significantly raises the risk of hypoglycaemia and requires dose monitoring.

Kidney Disease — Dibasic Calcium Phosphate's inorganic phosphate is nearly completely absorbed, and EFSA explicitly excludes renal-impaired individuals from its ADI; additionally, ACV's acetic acid may contribute to metabolic acidosis in those with compromised acid-base regulation.

Hypertension — Prolonged ACV use has been linked to hypokalaemia, which can exacerbate antihypertensive medication side effects and predispose individuals to cardiac rhythm disturbances.

Ibs — ACV's high acidity may worsen gastro-oesophageal reflux and gut mucosal irritation, while Triphala's laxative and motility-stimulating effects may exacerbate diarrhoea-predominant IBS.

Ibd — Triphala's laxative action may aggravate active inflammatory bowel disease flares despite its anti-inflammatory polyphenol content; physician guidance is required.

Liver Disease — Triphala inhibits hepatic CYP1A2, CYP3A4, CYP2C9, and CYP2D6 enzymes, altering the metabolism of many hepatically-cleared drugs in patients with impaired liver function.

Heart Disease — Triphala's CYP3A4 inhibition can raise plasma levels of statins, anticoagulants, and antiarrhythmics metabolized by this pathway, creating pharmacokinetic interactions with common cardiac medications.

The full analysis

Vlado's Himalayan Organics Apple Cider Vinegar 500mg is a 90-count vegetarian capsule supplement aimed at health-conscious Indian consumers seeking convenient ACV intake alongside Ayurvedic support from Triphala. It is FSSAI-licensed and free of allergens, artificial colours, and added sugars. However, the broad wellness claims — weight loss, glowing skin, energy boost, cholesterol management — are not supported by robust clinical evidence at a 500 mg encapsulated dose. The most important thing a consumer should know is that Triphala significantly inhibits multiple CYP450 enzymes, creating meaningful drug-interaction risks for anyone on prescription medications, and that the combined glucose-lowering effects of ACV and Triphala make this supplement genuinely risky for diabetics on medication without physician oversight.

FSSAI licence

11420850000150

Manufacturer

Mothersoul Pvt. Ltd.

Region

Source

MANUAL

Analysis

Independently researched